跳至主要内容
临床试验/NCT02329925
NCT02329925已完成不适用

The Efficacy of Tongue Stabilizing Device in Patients With Obstructive Sleep Apnea

University of British Columbia1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
41
试验地点
1
主要终点
Apnea-hypopnea index

研究概览

简要总结

The coordination of swallowing and breathing is an important mechanism because the route for air and deglutition is partly shared in the pharynx. Tongue Stabilizing Device (TSD) is a preformed appliance for Obstructive Sleep Apnea (OSA) that protrudes the tongue and improves upper airway structure and function during sleep. Investigators will attempt to assess efficacy of TSD therapy on OSA and the physiological change of swallowing and breathing routes in OSA patients during sleep.

详细描述

Purpose:

The purpose of this study is to determine the efficacy of TSD and to assess if it alters swallowing frequency and breathing modes in OSA patients during sleep.

Hypothesis:

Investigators hypothesize that TSD therapy will improve OSA symptoms and will lead to effective nasal breathing which may decrease swallowing frequency in OSA patients during sleep.

Justification:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients included in this study must:
  • •be 18 years of age or older
  • •have an objective diagnosis of mild to moderate obstructive sleep apnea (OSA) [5 ≤ AHI ≤ 50]; and
  • •have a Body Mass Index (BMI) ≤ 35

排除标准

  • •Patients are excluded in this study who:
  • •have had previous surgery of the soft palate;
  • •have neuromuscular disease;
  • •are taking medications which disturb sleep; and/or
  • •have ≤ 90% oxygen saturation levels for 20% of the night.

研究组 & 干预措施

Tongue Stabilizing Device Treatment

Experimental

Tongue Stabilizing Device (TSD) is a preformed appliance for OSA that protrudes the tongue and improves upper airway structure and function during sleep.

干预措施: Tongue Stabilizing Device (TSD) (Device)

结局指标

主要结局

Apnea-hypopnea index

时间窗: At 2-6 months of TSD treatment follow up

Measuring changes in apnea-hypopnea index (events/hour) to compare baseline and 2-6 months of TSD treatment follow up.

Frequency of swallowing

时间窗: At 2-6 months of TSD treatment follow up

Measuring changes in frequency of swallowing (events/hour) to compare baseline and 2-6 months of TSD treatment follow up.

Apnea-hypopnea index

时间窗: At baseline

Measuring apnea-hypopnea index (events/hour) to measure intervention efficacy (e.g. AHI)

Frequency of swallowing

时间窗: At baseline

Measuring frequency of swallowing (events/hour) to assess influence by intervention

次要结局

  • Functional Outcomes of Sleep Questionnaire (FOSQ) responses(At 2-6 months of TSD treatment follow up)
  • VR-36 survey responses(At 2-6 months of TSD treatment follow up)
  • Compliance (Measuring adherence (hours/nights and nights/week of intervention use))(At 2-6 months of TSD treatment follow up)
  • Epworth Sleepiness Scale (ESS) questionnaire responses.(At 2-6 months of TSD treatment follow up)
  • Breathing route(At 2-6 months of TSD treatment follow up)
  • Swallowing apnea time(At 2-6 months of TSD treatment follow up)
  • Functional Outcomes of Sleep Questionnaire (FOSQ) responses(At baseline)
  • Epworth Sleepiness Scale (ESS) questionnaire responses.(At baseline)
  • VR-36 survey responses(At baseline)
  • Breathing route(At baseline)
  • Swallowing apnea time(At baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fernanda Almeida

Principle Investigator

University of British Columbia

研究点 (1)

Loading locations...

相似试验